日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical Trial

乳腺肿瘤床活检用于病理完全缓解预测:NRG-BR005 非随机临床试验

Basik, Mark; Cecchini, Reena S; De Los Santos, Jennifer F; Umphrey, Heidi R; Julian, Thomas B; Mamounas, Eleftherios P; White, Julia R; Lucas, Peter C; Balanoff, Christa R; Tan, Antoinette R; Weber, Joseph J; Edmonson, David A; Brown-Glaberman, Ursa A; Diego, Emilia J; Teshome, Mediget; Matsen, Cindy B; Seaward, Samantha A; Wapnir, Irene L; Wagner, Jamie L; Tjoe, Judy A; Thompson, Alastair M; Wolmark, Norman

First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors

KHK2455单药治疗及联合mogamulizumab治疗晚期实体瘤患者的首次人体1期研究

Yap, Timothy A; Rixe, Olivier; Baldini, Capucine; Brown-Glaberman, Ursa; Efuni, Sergey; Hong, David S; Massard, Christophe; Muzaffar, Jameel; Varga, Andreea; Yilmaz, Emrullah; Ikawa, Yuta; Shiue, Lisa H; Liu, Yi; Hruska, Matthew W; Zhao, Henry; Tokunaga, Akihiro; Sahebjam, Solmaz

Comprehensive Longitudinal Linear Mixed Modeling of CTCs Illuminates the Role of Trop2, EpCAM, and CD45 in CTC Clustering and Metastasis

对循环肿瘤细胞进行全面的纵向线性混合模型分析,揭示了Trop2、EpCAM和CD45在循环肿瘤细胞聚集和转移中的作用

Merkley, Seth D; Kang, Huining; Brown-Glaberman, Ursa; Marchetti, Dario

Understanding the reasons for declining to participate in cancer genetics and genomic studies in the USA: a scoping review protocol

了解美国癌症遗传学和基因组学研究参与者拒绝参与的原因:一项范围界定审查方案

Sanchez Mendez, Joel; Sanchez, Jessica; Zhao, Chenya; Pankratz, Vernon Shane; Sussman, Andrew L; Brown-Glaberman, Ursa; Cargill, Stephanie; Mishra, Shiraz I; Stern, Mariana C

Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131

辅助铂类药物与卡培他滨治疗残留性浸润性三阴性乳腺癌:ECOG-ACRIN EA1131 研究中患者报告的结局

Smith, Karen L; Zhao, Fengmin; Mayer, Ingrid A; Tevaarwerk, Amye J; Garcia, Sofia F; Arteaga, Carlos L; Symmans, William F; Park, Ben H; Burnette, Brian L; Makower, Della F; Block, Margaret; Morley, Kimberly A; Jani, Chirag R; Mescher, Craig; Dewani, Shabana J; Brown-Glaberman, Ursa; Flaum, Lisa E; Mayer, Erica L; Sikov, William M; Rodler, Eve T; DeMichele, Angela M; Sparano, Joseph A; Wolff, Antonio C; Miller, Kathy D; Wagner, Lynne I

Developing questions to assess and measure patients' perceived survival benefit from adjuvant endocrine therapy in breast cancer: a mixed methods pilot study

制定评估和衡量乳腺癌患者从辅助内分泌治疗中感知到的生存获益的问题:一项混合方法试点研究

Tawfik, Bernard; Jacobson, Kendal; Brown-Glaberman, Ursa; Kosich, Mikaela; Van Horn, M Lee; Nemunaitis, Jacklyn; Dayao, Zoneddy; Pankratz, V Shane; Sussman, Andrew L; Guest, Dolores D

A Remotely Delivered Light-Intensity Physical Activity Intervention for Older Cancer Survivors: Protocol for a Feasibility Randomized Controlled Trial

针对老年癌症幸存者的远程低强度体育活动干预:可行性随机对照试验方案

Blair, Cindy K; Brown-Glaberman, Ursa; Walters, Scott T; Pestak, Claire; Boyce, Tawny; Barriga, Laura; Burgess, Ellen; Tawfik, Bernard; Killough, Cynthia; Kinney, Anita Y; Demark-Wahnefried, Wendy; Meisner, Angela L; Wiggins, Charles L; Pankratz, V Shane; Davis, Sally

A Pragmatic Cluster-Randomized Trial of a Standing Order Entry Intervention for Colony-Stimulating Factor Use Among Patients at Intermediate Risk for Febrile Neutropenia

一项针对中度发热性中性粒细胞减少症患者使用集落刺激因子的常规医嘱录入干预措施的实用性整群随机试验

Hershman, Dawn L; Bansal, Aasthaa; Sullivan, Sean D; Barlow, William E; Arnold, Kathryn B; Watabayashi, Kate; Bell-Brown, Ari; Le-Lindqwister, Nguyet A; Dul, Carrie L; Brown-Glaberman, Ursa A; Behrens, Robert J; Vogel, Victor; Alluri, Nitya; Ramsey, Scott D

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

Margetuximab 与 Trastuzumab 治疗既往接受过治疗的 HER2 阳性晚期乳腺癌患者(SOPHIA):一项随机 3 期试验的最终总生存期结果

Rugo, Hope S; Im, Seock-Ah; Cardoso, Fatima; Cortes, Javier; Curigliano, Giuseppe; Musolino, Antonino; Pegram, Mark D; Bachelot, Thomas; Wright, Gail S; Saura, Cristina; Escrivá-de-Romaní, Santiago; De Laurentiis, Michelino; Schwartz, Gary N; Pluard, Timothy J; Ricci, Francesco; Gwin, William R 3rd; Levy, Christelle; Brown-Glaberman, Ursa; Ferrero, Jean-Marc; de Boer, Maaike; Kim, Sung-Bae; Petráková, Katarína; Yardley, Denise A; Freedman, Orit; Jakobsen, Erik H; Gal-Yam, Einav Nili; Yerushalmi, Rinat; Fasching, Peter A; Kaufman, Peter A; Ashley, Emily J; Perez-Olle, Raul; Hong, Shengyan; Rosales, Minori Koshiji; Gradishar, William J

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

顺铂联合维利帕尼或安慰剂治疗转移性三阴性乳腺癌和BRCA突变相关乳腺癌(S1416):一项随机、双盲、安慰剂对照的II期试验

Rodler, Eve; Sharma, Priyanka; Barlow, William E; Gralow, Julie R; Puhalla, Shannon L; Anders, Carey K; Goldstein, Lori; Tripathy, Debu; Brown-Glaberman, Ursa A; Huynh, Thu-Tam; Szyarto, Christopher S; Godwin, Andrew K; Pathak, Harsh B; Swisher, Elizabeth M; Radke, Marc R; Timms, Kirsten M; Lew, Danika L; Miao, Jieling; Pusztai, Lajos; Hayes, Daniel F; Hortobagyi, Gabriel N